Abstract:Background: Recently, pyrido[2,3-d] pyrimidine, triazolopyrimidine, thiazolopyrimidine, quinoline, and pyrazole derivatives have gained attention due to their diverse biological activities, including antimicrobial, antioxidant, antitubercular, antitumor, anti-inflammatory, and antiviral effects. Objective: The synthesis of new heterocyclic compounds including 5-quinoline-pyrido[2,3-d] pyrimidinone (1–2, 4, 6–7), 6-quinoline-pyrido[2,3-d]thiazolo[3,2-a]pyrimidinone (3, 5, 8–10), 1,2,4-triazole-6-quinoline-pyrido[2,3-d]thiazolo[3,2-a]pyrimidinone (11–13), and pyrido[2,3-d]thiazolo[3,2-a]pyrimidine-ethyl-(pyridine)-9-thiaazabenzo[cd]azulenone (14) derivatives was performed with high yields while evaluating antimicrobial activities. Methods: A new series of quinoline-pyrido[2,3-d]thiazolo[3,2-a]pyrimidine derivatives were prepared using a modern style and advanced technology, resulting in high yields of these new compounds. Various reagents were utilized, specifically tailored to the production needs of each compound, through reactions that included alkylation, addition, condensation, acylation, the formation of Schiff bases, and intramolecular cyclization. Results: The chemical structures of the new compounds were determined using spectroscopy analyses, including IR, NMR, and MS, achieving good yields ranging from 68% to 90% under mild conditions in a regular system. All compounds were tested for in vitro antimicrobial activity and compared to standard drugs, specifically cefotaxime sodium and nystatin. The results showed that compounds 10 to 14 exhibited excellent antimicrobial activity, with a minimum inhibitory concentration (MIC) of 1 to 5 μmol/mL, compared to that of the standard drugs, which had MIC values of 1 to 3 μmol/mL. Furthermore, molecular docking studies were conducted to explore the interactions of specific compounds with antimicrobial target proteins. The findings revealed that compounds 10 to 14 displayed significant binding energies, with ΔG values ranging from −7.20 to −11.70 kcal/mol, indicating effective binding to the active sites of antimicrobial protein receptors. Conclusions: The SAR study confirmed a relationship between antimicrobial activity and the tested compounds. Molecular docking demonstrated that compounds 10, 11, 12, 13, and 14 exhibited significant binding energy, effectively interacting with the active sites of antimicrobial protein receptors. This consistent finding supports that these new compounds' practical and theoretical studies align regarding their antimicrobial activity.

Synthesis and Antibacterial Activity of New 3-Benzylspiro[benzo[h]quinazoline-5,1′-cycloheptan]-4(6H)-one Derivatives

Some Transformations of 2-Thioxo-2,3-Dihydro-1H-Spiro-[Benzo[h]Quinazoline-5,1′-Cycloheptan]-4(6H)-One and the Antibacterial and Antitumor Properties of the Compounds Synthesized

Synthesis and in vitro Antibacterial Activities of Some Bis-Oxazolidinones

STUDIES ON CONDENSED HETEROCYCLIC COMPOUNDS. XX. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF NOVEL 6-ARYL-3-(1-P-CHLOROPHENYL-5-METHYL-1,2,3-TRIAZOL-4-YL) -S-TRIAZOLO3,4-B-1,3,4- THIADIAZOLES

Synthesis and Biological Activity of 2-Mercapto-7,10-Dimethyl-3H-Spiro[Benzo[H]Quinazoline-5,1′-Cyclopentane]-4(6H)-One from Ethyl 4′-Amino-5′,8′-Dimethyl-1′H-Spiro[Cyclopentane-1,2′-Naphthalene]-3′-Carboxylate

Design, Synthesis, Antibacterial, and Antifungal Evaluation of a New Series of Quinazoline—Thiazole and /or Quinazoline—Triazole Hybrids as Bioactive Heterocycles

Synthesis and Antibacterial and Antitumor Properties of Derivatives of 5,5-Dimethyl-3-iso-Propyl-2-Thioxo-2,3,5,6-Tetrahydrobenzo[h]Quinazoline-4(1H)-One

Synthesis and Antibacterial Activity of 3-(3-methoxyphenyl)-2-methylsulfanyl-3Hquinazolin-4-one (4) and 3-(3-methoxyphenyl)-2-thioxo-2,3-dihydro1H-quinazolin-4-one (3) Via N-(3- methoxyphenyl)-methyl dithiocarbamic acid (2)

Synthesis of symmetrically substituted 3,3-dibenzyl-4-hydroxy-3,4-dihydro-1H-quinolin-2-ones, as novel quinoline derivatives with antibacterial activity

Synthesis, spectroscopic characterization, DFT calculations, in silico-ADMET and molecular docking analysis of novel quinoline-substituted 5H-chromeno [2,3-b] pyridine derivatives as antibacterial agents

Synthesis Of 3-Thioheterocycloyl-1,3,4,5-Tetrahdro-2-Oxo-1h-Benazepine

Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Novel Thiazoles, Pyrazoles, 1,3-Thiazepinones, and 1,2,4-Triazolopyrimidines Derived from Quinoline-Pyrido[2,3-d] Pyrimidinones

Synthesis and Antimicrobial Evaluation of Some Novel Bis-Hydroquinoline Derivatives

Synthesis, structure and antibacterial activity of new 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline derivatives.

Synthesis and Antibacterial Activities of Novel 4-Substituted-6-(4-chlorophenyl)-7-(lh-1,2,4-triazol-1-yl)-1 ',2 ',4 '-Triazolo[3,4-b]1 '',3 '',4 ''-Thiadiazines

Synthesis, Characterization, Antimicrobial and DFT Studies of Novel Quinolino‐Pyrazole Derivatives

Synthesis, Antibacterial Evaluation, Crystal Structure Determination, Hirshfeld Surface Analysis and Density Functional Theory Analysis of Novel 3-Amino-2-(2-Thienyl)-4(3H)-Quinazolinone

Synthesis, Characterization and Antibacterial Activity of Novel 2‐Oxo‐1,2‐dihydro‐1′H‐spiro[indoline‐3,2′‐quinazoline]‐4′‐carbohydrazones

Synthesis and antibacterial activities of novel hybrid molecules based on benzothiazole, benzimidazole, benzoxazole, and pyrimidine derivatives, each connected to N -arylacetamide and benzoate groups

Novel Quinoline-Based Thiosemicarbazide Derivatives: Synthesis, DFT Calculations, and Investigation of Antitubercular, Antibacterial, and Antifungal Activities

Synthesis And Antibacterial Activities Of 2-(1-Aryl-5-Methyl-1,2,3-Triazol-4-Yl)-1,3,4-Oxadiazole Derivatives